The goal of this observational study is to measure in real practice the performance and safety of RTR+Membrane, a synthetic dental membrane for guided tissue regeneration in periodontal or dental implant surgery. The main question it aims to answer is to measure the post-operative wound healing several months after surgery. Participants will be followed after their dental surgery via clinical examination and radiological and photos images.
Participants are any adult patients with one of the 3 following dental treatments to be done with RTR+Membrane: * post-extraction socket preservation, * alveolar ridge augmentation, * Guided Tissue Regeneration (GTR) during immediate implant placement. Since it is a real-life evidence study in current practice, patients will be followed at their surgery and their follow-ups. Below are listed visits and type of data collected. * V1 - Surgery: Demography, Medical history and concomitant treatments, Clinical/technical information (tooth extraction, surgery, membrane and grafting materials use), Clinical Exam, Photography, X-rays or Cone Beam Computed Tomography (CBCT) * V2 - Early follow-up (including suture removal, if needed): Clinical Exam, Questionnaire, Photography * V2bis - Early follow-up: Clinical Exam, Photography * V3 - Late follow-up: Clinical Exam, Photography, X-rays or CBCT, Questionnaire
Study Type
OBSERVATIONAL
Enrollment
90
* Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * V2bis (1 month +/- 1 week) - Early post-surgery follow-up * Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
* Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
Hospital University of Nantes
Nantes, France
RECRUITINGPrivate dental practice office of Dr. Alain Hoornaert
Nantes, France
RECRUITINGPost-operative wound healing measured by the Early Wound-Healing Index
For all groups The Early Wound-Healing Index (EHI) has the following best to worst scoring: (EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue. The EHI is evaluated at the Visit 3 (late post-surgery follow-up) for the primary outcome measure.
Time frame: up to 6 months
Post-operative wound healing measured by Early Wound-Healing Index
For all groups The Early Wound-Healing Index (EHI) has the following best to worst scoring: (EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue. The EHI is evaluated at the Visit 2 for this secondary outcome measure.
Time frame: up to 14 days
Post-operative wound healing measured by Early Wound Healing Score
For all groups The Early Wound Healing Score is from 0 (worse) to 10 (best). The EHS is evaluated at the Visit 2 for this secondary outcome measure.
Time frame: up to 14 days
Post-operative clinical exam
For all groups This is a descriptive secondary outcome measured by the investigator via the reporting of the presence or the absence of: * pain, * discomfort, * inflammation, * hematoma, redness, * swelling/suppuration, * membrane exposure, * dehiscence. The evaluation is done at visit 2, visit 2Bis, and visit 3.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
* Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement. * Visit 2 (10 days ± 4 days) - Early post-surgery follow-up * Visit 3 (3 months ± 1 month) - Late post-surgery follow-up
Private dental practice office of Dr. Samer Saloum-Rouxel
Nantes, France
NOT_YET_RECRUITINGPrivate dental practice office of Dr. Xavier Struillou
Nantes, France
NOT_YET_RECRUITINGPrivate dental practice office of Dr. Edouard Lanoiselée
Nozay, France
NOT_YET_RECRUITINGPrivate dental practice office of Dr. Aurélien Fruchet
Olonne-sur-Mer, France
NOT_YET_RECRUITINGPrivate dental practice office of Dr. Hélène Le Hécho
Orée d'Anjou, France
RECRUITINGPrivate dental practice office of Dr. Nicolas Strube
Orvault, France
NOT_YET_RECRUITINGPrivate dental practice office of Dr. Romain Besnier
Orvault, France
NOT_YET_RECRUITINGTime frame: up to 6 months
Number of adverse device effects (at least possibly) related to study device
For all groups
Time frame: up to 6 months
Oral Health-Related Quality of Life measured by the Oral Health Impact Profile (OHIP-5 items)
For all groups The 5 items of OHIP are: Difficulty chewing any foods; Painful aching in the mouth; Felt uncomfortable about the appearance of teeth; Less flavor in the food; and, Difficulty doing the usual jobs. Score is from 0 (best) to 20 (worse). The evaluation is done at visit 2 and visit 3.
Time frame: up to 6 months
Radiological measurements on CBCT
Only for Post-extraction socket preservation sub-group \& for Alveolar ridge augmentation sub-group The treatment efficacy is measured via the following measures on CBCT: A. Osseous changes in mesiodistal width of the alveolar ridge B. Osseous changes in height of the alveolar ridge C. Osseous changes in vestibulolingual dimension of the alveolar ridge. These changes are evaluated from Baseline to Visit 3.
Time frame: up to 6 months
Radiological measurements on retro-alveolar radios
Only for Guided Tissue Regeneration (GTR) during immediate implant placement subgroup. The treatment efficacy is measured via the following measures: A. Distal vertical situation of the bone plateau compared to the implant by retroalveolar radiography B. Mesial vertical situation of the bone plateau compared to the implant by retroalveolar radiography C. Insertion Torque Value (Ncm) These changes are evaluated from Baseline to Visit 3.
Time frame: up to 4 months